Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Amortizatization of Intangibles (2019 - 2025)

KalVista Pharmaceuticals' Amortizatization of Intangibles history spans 7 years, with the latest figure at $3000.0 for Q2 2025.

  • For Q2 2025, Amortizatization of Intangibles fell 25.0% year-over-year to $3000.0; the TTM value through Apr 2025 reached $17000.0, down 81.52%, while the annual FY2025 figure was $14000.0, 84.78% down from the prior year.
  • Amortizatization of Intangibles for Q2 2025 was $3000.0 at KalVista Pharmaceuticals, down from $5000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $62000.0 in Q3 2023 and bottomed at $3000.0 in Q2 2025.
  • The 3-year median for Amortizatization of Intangibles is $5000.0 (2024), against an average of $15000.0.
  • The largest annual shift saw Amortizatization of Intangibles crashed 91.94% in 2024 before it decreased 25.0% in 2025.
  • A 3-year view of Amortizatization of Intangibles shows it stood at $21000.0 in 2023, then plummeted by 76.19% to $5000.0 in 2024, then tumbled by 40.0% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for KALV's Amortizatization of Intangibles are $3000.0 (Q2 2025), $5000.0 (Q4 2024), and $5000.0 (Q3 2024).